Break it Down: PharmAust cashes up for the fight against MND

Link copied to
clipboard

Stockhead’s Break it Down brings you today’s leading market news in under 90 seconds.

In this episode, host Fraser Palamara dives into the mega $10 million raising PharmAust (ASX:PAA) announced today via an institutional placement.

Funds from the raising will be used to support preparations for an important study in treating patients with motor neurone disease to take place in the second half of this year.

Tune in to get the latest.

While PharmAust is a Stockhead advertiser, it did not sponsor this content.

share

• 
• 
• 
• 

Link copied to
clipboard

SUBSCRIBE

Get the latest Stockhead news delivered free to your inbox.

Name*

Email*

Hidden

Email Lists

Morning Update

Lunch Update

Market Close Update

Weekend Update

Spotlight

Name

This field is for validation purposes and should be left unchanged.

It's free. Unsubscribe whenever you want.

By proceeding, you confirm you understand that we handle personal information in accordance with our Privacy Policy.

You might be interested in

Long Shortz

Long Shortz with Neurizon Therapeutics: Goodbye to PharmAust, hello to neuro horizons

October 23, 2024 | Stockhead TV

Long Shortz

Long Shortz with PharmAust: Sweet incentives for sad disease's drug development

September 30, 2024 | Stockhead TV

Prepped and Primed

2023 Prepped and Primed: PharmAust (ASX:PAA) with general manager, Fiona Milner

January 23, 2023 | Stockhead TV